Valion Bio, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| VBIO | VAL.L | CLDI | TOVX | AIM | NIKI | |
|---|---|---|---|---|---|---|
| Market cap | 1.08M | 2.11M | 2.68M | 8.72M | 6.42M | 5.27M |
| P/E (TTM) | — | — | — | 0.3 | — | — |
| Forward P/E | — | 0.0 | -0.8 | -1.0 | -0.4 | — |
| Price/book | 0.0 | 0.4 | 0.5 | 0.7 | 0.6 | 0.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −99.08% | −31.91% | −97.25% | −29.63% | −90.12% | −87.62% |
| Today | −2.60% | 0.00% | −2.54% | +4.40% | +0.19% | −3.98% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All VBIO news ›Valion Bio Weighs Strategic Options After Unsolicited Interest in Velocity Bioworks
TradingView Valion Bio Weighs Strategic Options After Unsolicited Interest in Velocity Bioworks Valion Bio received unsolicited acquisition inquiries for Velocity Bioworks and is evaluating strategic options, includ
Antibody Manufacturing Costs Have Fallen From $35 to About $12 per Gram, Says IIT Delhi’s Anurag Rathore
In the final part of a three-part interview, Anurag Rathore, PhD, professor of chemical engineering at IIT Delhi, explains how his team has cut monoclonal antibody costs toward $10 per gram and why process intensification will spread one…
Head-To-Head Comparison: Valion Bio, Inc. Common Stock (NASDAQ:VBIO) versus Halozyme Therapeutics (NASDAQ:HALO)
Posted by Tristan Rich on Oct 30th, 2026 Valion Bio, Inc. Common Stock (NASDAQ:VBIO – Get Free Report) and Halozyme Therapeutics (NASDAQ:HALO – Get Free Report) are both healthcare companies, but which is the better stock? We will compare…
Valion Bio Announces Reverse Stock Split
The new CUSIP for the Company's common stock following the reverse split will be 918942202. The reverse stock split will not affect the number of shares of preferred stock issued and outstanding, the number of shares of common stock or…
More from 1 other outlet
Valion Bio Announces Changes to Management and Board of Directors
Current CFO, Lisa Wolf named President and COO, assuming expanded executive and operational leadership. Jared Malbin and Thomas Jensen appointed as directors. Focused on Value Creation: Streamlined leadership and additional Board expertise…
Alvotech (NASDAQ:ALVO) & Valion Bio, Inc. Common Stock (NASDAQ:VBIO) Head to Head Survey
Posted by Defense World Staff on Oct 26th, 2026 Alvotech (NASDAQ:ALVO – Get Free Report) and Valion Bio, Inc. Common Stock (NASDAQ:VBIO – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will…
Valion Bio's New Leadership Unveils 30-Day Agenda to Accelerate Clinical Pipeline and Unlock Shareholder Value
Entolimod: A Government-Backed Lead Asset with Multiple Paths Forward Entolimod's development is now advancing on several fronts: "Commercial execution and strategic flexibility are not mutually exclusive," said Mr. Zikria. "We are…
ValiRx highlights 5.55% Ambrose Healthcare stake following €161 million AM-Pharma acquisition
ValiRx Plc (AIM: VAL) has highlighted its indirect 5.55% shareholding in Ambrose Healthcare following the private pharmaceutical company’s agreement to acquire AM-Pharma for up to €161 million, drawing investor attention to the potential…
Valion Bio, Inc. Common Stock (NASDAQ:VBIO) vs. Arcus Biosciences (NYSE:RCUS) Head-To-Head Comparison
Posted by Sarita Garza on Oct 18th, 2026 Valion Bio, Inc. Common Stock (NASDAQ:VBIO – Get Free Report) and Arcus Biosciences (NYSE:RCUS – Get Free Report) are both healthcare companies, but which is the superior investment? We will…
Valion Bio Seeks Stockholder Approval for Reverse Stock Split and 272,000 Share Equity Plan Increase
Kalkine Media On October 16, 2026, Valion Bio, Inc. submitted a definitive proxy statement requesting stockholder approval for a reverse stock split, an increase of shares in its equity incentive pla
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktitan.net7
- financialcontent.com3
- themarketsdaily.com3
- digitaljournal.com2
- guardonline.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 28 articles, not a forecast.